? PHARMACOANALYTICAL SHARED RESOURCE (PhASR) PhASR provides CCC members with expertise in pharmacokinetic (PK) and pharmacodynamic (PD) studies, including bioanalytical services to accurately quantify drugs, metabolites, and endogenous biomolecules in biological samples to support pre-clinical and clinical development of experimental cancer therapies. This support also includes experimental design, data analysis, modeling and simulation for characterizing PK/PD relationships and simulating optimal dose regimens for the advancement of anti-cancer therapies in pre-clinical and clinical development stages. PhASR was previously rated as Outstanding in the Analytical Shared Resource Group. There were no weaknesses noted, but it was recommended that PhASR plan for anticipated increases for future demand. PhASR?s Specific Aims are to: 1) develop and validate new assays to quantify drugs and metabolites in biological specimens; 2) quantify drug and metabolite levels in biological matrices, and conduct PK/PD studies for incorporation into pre-clinical and clinical decision-making; and 3) provide expertise in PK/PD study design and data interpretation to support submission of early phase 1 and 2 clinical protocols, grants, and publications. During the current 5-year funding cycle, PhASR supported 67 investigators in all five OUSCCC research programs and Nationwide Children?s Hospital, and supported 52 publications (8 with >10 impact factor) and 11 NCI grants, including 1 K22, 1 K24, 2 P01s, 2 P50s, 4 R01s, and 1 UM1. PhASR future services will address OSUCCC strategic priorities in translational genomics, immuno-oncology and cancer engineering. Given the robust OSUCCC recruitment, demand for services and new technologies will increase. The PhASR will expand its staff, instrumentation and services before capacity is reached. Recent and new technologies on order will enhance our efforts for accurate and sensitive measurements in samples of small quantity, focus on development of assays to accurately quantify immunotherapies and other biologics and increase statistical modeling services for PK/PD relationships at the cellular, tumor, organ, or whole body levels. The annual budget of the PhASR is $612,272 yet the CCSG request is $94,171. As such, the PhASR leverages extensive institutional support and seeks only 15.4% support from CCSG funds.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016058-45
Application #
10090016
Study Section
Subcommittee H - Clinical Groups (NCI)
Project Start
1997-09-12
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Talbert, Erin E; Lewis, Heather L; Farren, Matthew R et al. (2018) Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naïve pancreatic cancer patients. J Cachexia Sarcopenia Muscle 9:358-368
Wang, Jin-Ting; Xie, Wen-Quan; Liu, Fa-Quan et al. (2018) NADH protect against radiation enteritis by enhancing autophagy and inhibiting inflammation through PI3K/AKT pathway. Am J Transl Res 10:1713-1721
Karpurapu, Manjula; Lee, Yong Gyu; Qian, Ziqing et al. (2018) Inhibition of nuclear factor of activated T cells (NFAT) c3 activation attenuates acute lung injury and pulmonary edema in murine models of sepsis. Oncotarget 9:10606-10620
Norquist, Barbara M; Brady, Mark F; Harrell, Maria I et al. (2018) Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study. Clin Cancer Res 24:777-783
Zhang, Bin; Nguyen, Le Xuan Truong; Li, Ling et al. (2018) Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nat Med 24:450-462
Tasselli, Giorgia; Filippucci, Sara; Borsella, Elisabetta et al. (2018) Yeast lipids from cardoon stalks, stranded driftwood and olive tree pruning residues as possible extra sources of oils for producing biofuels and biochemicals. Biotechnol Biofuels 11:147
Moliva, J I; Hossfeld, A P; Canan, C H et al. (2018) Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8+ T-cell-dependent manner. Mucosal Immunol 11:968-978
Suarez-Kelly, Lorena P; Akagi, Keiko; Reeser, Julie W et al. (2018) Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity. Cold Spring Harb Mol Case Stud 4:
Malpeli, Giorgio; Barbi, Stefano; Greco, Corinna et al. (2018) MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma. Oncotarget 9:19961-19979
McRee, Annie-Laurie; Shoben, Abigail; Bauermeister, Jose A et al. (2018) Outsmart HPV: Acceptability and short-term effects of a web-based HPV vaccination intervention for young adult gay and bisexual men. Vaccine 36:8158-8164

Showing the most recent 10 out of 2602 publications